Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients

por Han, Weiguo, Wang, Tao, Reilly, Andrew A, Keller, Steven M, Spivack, Simon D
Publicado 2009

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Tr...

por Jabbour, Salma K., Lee, Ki Hyeong, Frost, Nikolaj, Breder, Valeriy, Kowalski, Dariusz M., Pollock, Theodore, Levchenko, Evgeny, Reguart, Noemi, Martinez-Marti, Alex, Houghton, Baerin, Paoli, Jean-Baptiste, Safina, Sufia, Park, Keunchil, Komiya, Takefumi, Sanford, Amy, Boolell, Vishal, Liu, Hong, Samkari, Ayman, Keller, Steven M., Reck, Martin
Publicado 2021

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

por Wakelee, Heather A., Dahlberg, Suzanne E., Keller, Steven M., Tester, William J., Gandara, David R., Graziano, Stephen L., Adjei, Alex, Leighl, Natasha B., Aisner, Seena C., Rothman, Jan M., Patel, Jyoti D., Sborov, Mark D., McDermott, Sean R., Perez-Soler, Roman, Traynor, Anne M., Butts, Charles, Evans, Tracey, Shafqat, Atif, Chapman, Andrew E., Kasbari, Samer S., Horn, Leora, Ramalingam, Suresh S., Schiller, Joan
Publicado 2017